Showing results (141-150 of 231) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxelDeborah Toppmeyer, Andrew D Seidman, Michael Pollak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancerAlan I So, Randy J Levitt, Bernhard Eigl, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 19, 2017
Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?Leticia M Nogueira, Christina C Newton, Michael Pollak, et al.
International Journal of Cancer|September 21, 2011
Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenomaYing Gao, Hormuzd Katki, Barry Graubard, et al.
Breast Cancer Research : BCR|September 20, 2005
Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumoursJill E Kucab, Cathy Lee, Ching-Shih Chen, et al.
Cancers|November 26, 2022
The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer CellsMaxime Parisotto, Nhung Vuong-Robillard, Paloma Kalegari, et al.
The Journal of Urology|February 23, 2010
Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation modelJessica C Lloyd, Jodi A Antonelli, Tameika E Phillips, et al.
Experimental Hematology|May 23, 2012
IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoproteinCatherine E Jenkins, Olena O Shevchuk, Vincenzo Giambra, et al.
Annals of Surgical Oncology|February 7, 2026
Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose TamoxifenNatasha J Stonebanks Cuillerier, Hamda Almarzooqi, Victor Villareal-Corpuz, et al.
Cancer Research|July 13, 2011
Insulin increases de novo steroidogenesis in prostate cancer cellsAmy A Lubik, Jennifer H Gunter, Stephen C Hendy, et al.
Pageof 24